1-naphthol has been researched along with Breast Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bastow, KF; Dong, Y; Kim, Y; Lai, CY; Lee, EY; Lee, KH; Morris-Natschke, SL; Nakagawa-Goto, K | 1 |
| Akizuki, K; Hirano, T; Ishida, A; Ishihara, Y; Kameshita, I; Murai, T; Ozaki, H; Shimoda, N; Sueyoshi, N; Yamazaki, T | 1 |
2 other study(ies) available for 1-naphthol and Breast Neoplasms
| Article | Year |
|---|---|
Antitumor agents. 289. Design, synthesis, and anti-breast cancer activity in vivo of 4-amino-2H-benzo[h]chromen-2-one and 4-amino-7,8,9,10-tetrahydro-2H-benzo[h]chromen-2-one analogues with improved water solubility.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Chromones; Drug Design; Humans; Mice; Molecular Structure; Solubility; Water | 2012 |
CaMK phosphatase (CaMKP/POPX2/PPM1F) inhibitors suppress the migration of human breast cancer MDA-MB-231 cells with loss of polarized morphology.
Topics: Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line, Tumor; Cell Movement; Female; Humans; MDA-MB-231 Cells; Naphthols; Phosphoprotein Phosphatases | 2023 |